BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 22633347)

  • 1. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
    Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
    Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boston keratoprosthesis type 1 device leak.
    Najem K; Sebag M; Harissi-Dagher M
    Can J Ophthalmol; 2014 Feb; 49(1):106-8. PubMed ID: 24513367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Concurrent Boston Type I Keratoprosthesis and Glaucoma Drainage Device Implantation.
    Lenis TL; Chiu SY; Law SK; Yu F; Aldave AJ
    Ophthalmology; 2017 Jan; 124(1):12-19. PubMed ID: 27614591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
    Robert MC; Pomerleau V; Harissi-Dagher M
    Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boston type 1 keratoprosthesis for primary congenital glaucoma.
    Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
    Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
    Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
    J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
    Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
    Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes Using Oversized Back Plates in Type I Boston Keratoprosthesis.
    Kaufman AR; Cruzat A; Colby KA
    Eye Contact Lens; 2018 Nov; 44(6):399-404. PubMed ID: 29219899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
    Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
    Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
    Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
    Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.